A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome.
Kenichiro Kudo, Eiki Ichihara, Akiko Hisamoto, Katsuyuki Hotta, Nobuaki Miyahara, Yasushi Tanimoto, Sadaharu Akagi, Katsuya Kato, Mitsune Tanimoto, Katsuyuki Kiura
Index: Intern. Med. 52(1) , 97-100, (2013)
Full Text: HTML
Abstract
A 32-year-old male with CATCH22 syndrome presented with a high fever and productive cough after taking drugs for acute bronchitis, including (L)-carbocisteine. Chest radiography revealed ground-glass opacities in the bilateral lung fields. He had a history of similar pneumonia. Under the assumption of drug-induced pneumonia, or bacterial or viral pneumonia, all drugs including (L)-carbocisteine were discontinued, and antibiotics were started. A drug-induced lymphocyte stimulation test was positive only for (L)-carbocisteine. The only drug in common between this and the previous episode of pneumonia was (L)-carbocisteine. We thus concluded that this was a definite case of (L)-carbocisteine-induced pneumonia in a patient with CATCH22 syndrome.
Related Compounds
Related Articles:
2008-11-13
[J. Med. Chem. 51 , 6740-51, (2008)]
2008-01-01
[Toxicol. Mech. Methods 18 , 217-27, (2008)]
Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.
2007-07-15
[Bioorg. Med. Chem. Lett. 17 , 3921-4, (2007)]
2011-04-15
[Biochem. Pharmacol. 81(8) , 1043-53, (2011)]
Disulphide linkage in mouse ST6Gal-I: determination of linkage positions and mutant analysis.
2012-02-01
[J. Biochem. 151(2) , 197-203, (2012)]